IL-4 Promotes NLRP3 Nuclear Localization in Malignant CD4+ T Cells, and Tumor Lesions Show Augmented NLRP3 Expression in CTCL. Here, NLRP3 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.